Delivery Order SPE2DB22D1106-SPE2DB24FDTA9
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 150mg pharmaceutical products, with a ceiling value of $6,626.06 and an ultimate completion date of August 7, 2024. The contract is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
- This federal contract award, valued at $1,684.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565158696 - CLINDAMYCIN 60ML 1S, a pharmaceutical product. The contract has a completion date of July 17, 2024 and is a Firm Fixed Price Delivery Order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a firm fixed price of $1,544.32. The contract is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, to support Defense Logistics Agency (DLA) Troop Support Medical programs. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,398.72 firm fixed price contract is for the supply of 4565357729 ! CLINDAMYCIN 600 MG/50 ML-D5W 50ML, with a completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to...
- This federal contract award is for the delivery of CLINDAMYCIN PH 900 MG/6 ML VL 6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract has a ceiling value of $4,627.25 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of May 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken,...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product. The contract is not set aside and has a ceiling value of $2,599.76. The ultimate completion date is June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,223.87, is for the delivery of Clindamycin PH 1% Solution 60ML and has an ultimate completion date of April 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,632.26 firm fixed-price contract is for the delivery of Clindamycin PH 900 mg/6 ml vials. The award is not set-aside and has an ultimate completion date of June 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,709.23, is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.13 firm fixed price delivery order is for the supply of 4568513111 - CLINDAMYCIN 150MG 100S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDTA9Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a Ceiling Value of $6,050.85, is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an Ultimate Completion Date of January 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 1/2/24 |